Business Description
Tempest Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US87978U1088
Description
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.59 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.99 | |||||
Debt-to-EBITDA | -0.73 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 14.2 | |||||
3-Year EPS without NRI Growth Rate | 12.9 | |||||
3-Year FCF Growth Rate | 14.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 10.06 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 17.75 | |||||
9-Day RSI | 21.05 | |||||
14-Day RSI | 24.91 | |||||
6-1 Month Momentum % | -19 | |||||
12-1 Month Momentum % | 162.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.13 | |||||
Quick Ratio | 3.13 | |||||
Cash Ratio | 3.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -49.2 | |||||
Shareholder Yield % | -83.13 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -239.27 | |||||
ROA % | -79.13 | |||||
ROIC % | -171.56 | |||||
ROC (Joel Greenblatt) % | -250.04 | |||||
ROCE % | -97.97 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.17 | |||||
Price-to-Tangible-Book | 2.17 | |||||
EV-to-EBIT | -1.16 | |||||
EV-to-Forward-EBIT | -0.93 | |||||
EV-to-EBITDA | -1.18 | |||||
EV-to-Forward-EBITDA | -0.93 | |||||
EV-to-FCF | -1.24 | |||||
Price-to-Net-Current-Asset-Value | 4.59 | |||||
Price-to-Net-Cash | 5.18 | |||||
Earnings Yield (Greenblatt) % | -86.21 | |||||
FCF Yield % | -59.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TPST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tempest Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1.72 | ||
Beta | -2.81 | ||
Volatility % | 1262.12 | ||
14-Day RSI | 24.91 | ||
14-Day ATR ($) | 0.196135 | ||
20-Day SMA ($) | 2.5235 | ||
12-1 Month Momentum % | 162.31 | ||
52-Week Range ($) | 0.17 - 9.77 | ||
Shares Outstanding (Mil) | 22.22 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tempest Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tempest Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Tempest Therapeutics Inc Frequently Asked Questions
What is Tempest Therapeutics Inc(TPST)'s stock price today?
The current price of TPST is $2.02. The 52 week high of TPST is $9.77 and 52 week low is $0.17.
When is next earnings date of Tempest Therapeutics Inc(TPST)?
The next earnings date of Tempest Therapeutics Inc(TPST) is 2024-08-30 Est..
Does Tempest Therapeutics Inc(TPST) pay dividends? If so, how much?
Tempest Therapeutics Inc(TPST) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |